Stock Performance Overview
The stock closed just 2.56% above its 52-week low of ₹38, signalling persistent weakness. Over the past year, Nirman Agri Genetics Ltd has delivered a negative return of 76.02%, starkly contrasting with the Sensex’s modest decline of 2.39% during the same period. Year-to-date, the stock has fallen by 40.52%, while the benchmark index has dropped 7.68%. The three-year performance is particularly notable, with the stock losing 78.27% against the Sensex’s 20.60% gain.
Shorter-term trends also reflect sustained pressure. The stock declined 12.47% over the past week and 16.25% in the last month, compared to the Sensex’s respective gains of 2.40% and 1.17%. Over three months, the stock’s fall of 32.14% contrasts with the Sensex’s 2.29% rise. These figures highlight a consistent underperformance relative to the broader market.
Technical Indicators and Moving Averages
Technically, Nirman Agri Genetics Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning underscores the prevailing bearish momentum. Immediate resistance is noted at ₹40.82, corresponding to the 20-day moving average, with further resistance levels at ₹46.54 (100 DMA) and ₹60.38 (200 DMA).
Market Capitalisation and Quality Assessment
The company is classified as a micro-cap stock, reflecting its relatively small market capitalisation. The overall quality grade is not available, with financial performance-based quality assessments currently unreported. Management risk, growth, and capital structure details remain undisclosed, limiting comprehensive quality evaluation.
Financial Performance and Recent Results
Despite the stock’s decline, Nirman Agri Genetics Ltd has reported positive financial results in recent quarters. The company posted a 3.16% growth in net sales in March 2025 and has declared positive results for four consecutive quarters. The latest six-month figures reveal net sales of ₹124.07 crores, representing a substantial growth of 215.30%, while profit after tax (PAT) rose by 110.65% to ₹13.65 crores. Quarterly PBDIT reached a high of ₹7.31 crores.
Return on equity (ROE) stands at 13.8%, indicating a reasonable level of profitability relative to shareholder equity. The stock’s price-to-book value ratio is notably low at 0.2, suggesting an attractive valuation metric from a book value perspective.
Valuation and Dividend Information
Valuation multiples such as price-to-earnings (P/E) ratio, EV/EBITDA, and PEG ratio are not available, reflecting either a lack of reported earnings or insufficient data. The company declared a dividend of ₹2 per share, with an ex-dividend date of 25 September 2024. Dividend yield and payout ratios remain undisclosed.
Trading Volumes and Delivery Trends
Recent trading activity shows a 1-month delivery volume increase of 19.71%, with a significant 60.32% rise in delivery volume on the day of the price drop compared to the 5-day average. On 31 July 2026, delivery volume accounted for 79.55% of total volume, higher than the trailing one-month average of 70.26% and the previous month’s 74.14%. These figures indicate heightened trading interest amid the price decline.
Market Context and Comparative Performance
Within the Other Agricultural Products sector, Nirman Agri Genetics Ltd has underperformed its peers and the broader BSE500 index over multiple time frames. The stock’s negative returns over one year, three months, and three years contrast with the sector’s relative stability and the broader market’s positive trends. This divergence emphasises the stock’s ongoing challenges in regaining investor confidence.
Rating and Mojo Score
MarketsMOJO assigns the stock a Mojo Score of 37.0, categorising it as a 'Sell'. This rating was downgraded from a previous 'Strong Sell' on 1 June 2026, reflecting a slight improvement in outlook but maintaining a cautious stance. The downgrade aligns with the company’s weak long-term fundamental strength, notably due to the absence of declared results over the past six months.
Summary of Key Metrics
To summarise, Nirman Agri Genetics Ltd’s stock has reached an all-time low amid a sustained downtrend characterised by significant underperformance relative to the Sensex and sector benchmarks. While recent financial results show growth in sales and profits, the stock’s valuation and trading patterns reflect ongoing market scepticism. The company’s micro-cap status and limited disclosure on quality metrics add to the complexity of its market position.
Investors and market participants will continue to monitor the stock’s price action and financial disclosures closely as it navigates this challenging phase.
